| Network modeling of microRNA–mRNA interactions in neuroblastoma tumorigenesis identifies miR-204 as a direct inhibitor of MYCN CY Ooi, DR Carter, B Liu, C Mayoh, A Beckers, A Lalwani, Z Nagy, ... Cancer research 78 (12), 3122-3134, 2018 | 53 | 2018 |
| Function of RasGRP3 in the formation and progression of human breast cancer Z Nagy, I Kovács, M Török, D Tóth, G Vereb, K Buzás, I Juhász, ... Molecular cancer 13 (1), 1-17, 2014 | 46 | 2014 |
| Inhibition of TASK-3 (KCNK9) channel biosynthesis changes cell morphology and decreases both DNA content and mitochondrial function of melanoma cells maintained in cell culture L Kosztka, Z Rusznák, D Nagy, Z Nagy, J Fodor, G Szucs, A Telek, ... Melanoma research 21 (4), 308-322, 2011 | 46 | 2011 |
| An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability Z Nagy, JA Seneviratne, M Kanikevich, W Chang, C Mayoh, P Venkat, ... Nature communications 12 (1), 1-20, 2021 | 40 | 2021 |
| Silencing the KCNK9 potassium channel (TASK-3) gene disturbs mitochondrial function, causes mitochondrial depolarization, and induces apoptosis of human melanoma cells D Nagy, M Gönczi, B Dienes, Á Szöőr, J Fodor, Z Nagy, A Tóth, T Fodor, ... Archives of dermatological research 306 (10), 885-902, 2014 | 38 | 2014 |
| Withaferin A activates TRIM16 for its anti-cancer activity in melanoma Z Nagy, BB Cheung, W Tsang, O Tan, M Herath, OC Ciampa, F Shadma, ... Scientific reports 10 (1), 1-9, 2020 | 31 | 2020 |
| A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma BB Cheung, A Kleynhans, R Mittra, PY Kim, JK Holien, Z Nagy, ... Oncogene 40 (13), 2367-2381, 2021 | 17 | 2021 |
| Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma JL Bell, S Hagemann, JK Holien, T Liu, Z Nagy, JH Schulte, D Misiak, ... International journal of molecular sciences 21 (14), 5098, 2020 | 17 | 2020 |
| ESR1 fusions and therapeutic resistance in metastatic breast cancer Z Nagy, R Jeselsohn Frontiers in Oncology 12, 1037531, 2023 | 13 | 2023 |
| Purkinje-like cells of the rat cochlear nucleus: a combined functional and morphological study Á Kőszeghy, B Pál, P Pap, K Pocsai, Z Nagy, G Szűcs, Z Rusznák Brain research 1297, 57-69, 2009 | 8 | 2009 |
| A distinct chromatin state drives therapeutic resistance in invasive lobular breast cancer A Nardone, X Qiu, S Spisak, Z Nagy, A Feiglin, A Feit, G Cohen Feit, Y Xie, ... Cancer Research 82 (20), 3673-3686, 2022 | 7 | 2022 |
| Cytoplasmic Ca2+ concentration changes evoked by muscarinic cholinergic stimulation in primary and metastatic melanoma cell lines D Nagy, L Kosztka, P Pap, Z Nagy, Z Rusznák, L Csernoch, G Szücs Melanoma research 21 (1), 12-23, 2011 | 7 | 2011 |
| Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma JA Seneviratne, DR Carter, R Mittra, A Gifford, PY Kim, JS Luo, C Mayoh, ... International Journal of Cancer 152 (7), 1399-1413, 2023 | 6 | 2023 |
| Protein kinase Cδ promotes proliferation and induces malignant transformation in skeletal muscle G Czifra, A Szöllősi, Z Nagy, M Boros, I Juhász, A Kiss, F Erdődi, T Szabó, ... Journal of cellular and molecular medicine 19 (2), 396-407, 2015 | 6 | 2015 |
| Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer F Hermida-Prado, Y Xie, S Sherman, Z Nagy, D Russo, T Akhshi, Z Chu, ... Cancer Research 83 (19), 3284-3304, 2023 | 2 | 2023 |
| Alyref is a novel binding partner and co-factor for MYCN-driven oncogenesis in neuroblastoma Z Nagy, M Kanikevich, J Koach, C Mayoh, D Carter, T Liu, Y Du, C Jiang, ... Cancer Research 79 (13 Supplement), 3659-3659, 2019 | | 2019 |
